[ORGANIZATION]
Medincell
Featured in 2 tracked stories · first seen
Situations
FDA approval of Weltruza for schizophrenia
2 clusters · 6 sources · last updated
Latest: FDA approves Weltruza monthly subcutaneous olanzapine injection
The U.S. Food and Drug Administration (FDA) has approved Weltruza, a once-monthly subcutaneous olanzapine injection for the treatment of schizophrenia in adults. Developed by Teva Pharmaceutical Industries in partnership